Person: Karimah Es Sabar

Sean Cunliffe

Sean Cunliffe has been appointed CEO of Sitka Biopharma Inc, a spinoff of CDRD Ventures Inc (see brief on this page). Cunliffe is a pharmaceutical sales and marketing executive with more than 30 years of experience working in big pharma. At Sitka he will work with founding scientists Dr Helen Burt and Dr Don Brooks…

Karimah Es Sabar

Karimah Es Sabar has been selected as a recipient of the Canada’s Most Powerful Women Top 100 Awards for 2013 by the Women’s Executive Network’s . Esabar is president and CEO of the Centre for Drug Research and Development (CDRD), Vancouver and founding chair of the Global Alliance of Leading Drug Discovery and Development Centres.…

Mark Lievonen

Mark Lievonen, president of Sanofi Pasteur Ltd, has been appointed chair of the board of directors for Canada’s Research-Based Pharmaceutical Companies (Rx&D) for 2013-14. Lievonen joined Sanofi Pasteur in 1983 and held a number of senior positions before being named president in 1999. Lievonen holds a BBA in accounting and an MBA from the Schulich…

Sean Cunliffe

Sean Cunliffe has been appointed CEO of Sitka Biopharma Inc, a spinoff of CDRD Ventures Inc (see brief on this page). Cunliffe is a pharmaceutical sales and marketing executive with more than 30 years of experience working in big pharma. At Sitka he will work with founding scientists Dr Helen Burt and Dr Don Brooks…

Karimah Es Sabar

Karimah Es Sabar has been selected as a recipient of the Canada’s Most Powerful Women Top 100 Awards for 2013 by the Women’s Executive Network’s . Esabar is president and CEO of the Centre for Drug Research and Development (CDRD), Vancouver and founding chair of the Global Alliance of Leading Drug Discovery and Development Centres.…

Mark Lievonen

Mark Lievonen, president of Sanofi Pasteur Ltd, has been appointed chair of the board of directors for Canada’s Research-Based Pharmaceutical Companies (Rx&D) for 2013-14. Lievonen joined Sanofi Pasteur in 1983 and held a number of senior positions before being named president in 1999. Lievonen holds a BBA in accounting and an MBA from the Schulich…

Dr David Lizius

Dr David Lizius has been appointed president and CEO of COM DEV Canada, the Ottawa-based division of COM DEV International Ltd, Cambridge ON. Lizius replaces George Cwynar, a veteran high-tech executive and former CEO of Mosaid Technologies who left abruptly after 18 months at COM DEV to “pursue other opportunities”. Lizius has 30 years of…

Karimah Es Sabar

Karimah Es Sabar has been appointed senior VP business and strategic affairs with the Centre for Drug Research and Development (CDRD) as the Vancouver-based organization expands activities across Canada and internationally. Es Sabar is currently president of Life Sciences BC and will take on joint responsibilities with both organizations until April/10 when she assumes CDRD…

Howard Gwin

Howard Gwin has joined Bridge-scale Partners as a venture partner operating out of the Menlo Park CA-based investment firm’s Toronto offices. Gwin is a veteran of the software and services sectors and sits on the board of several Canadian software companies. Prior to joining Bridgescale, he was president of Solect Technology Group and held executive…

Dr André Musy

Dr André Musy has been appointed DG of Ouranos, the research institute of Hydro-Québec. Musy comes to Ouranos from the École Polytechnique Fédérale de Lausanne (EPFL). His experience in hydrology, the environment and land and water use is well suited to Ouranos’ two-pronged research program of climate science/hydrology and impacts and adaptation strategies. Musy holds…